U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage
Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by the NIH to develop a new treatment for preventing nerve damage. “This is a case of ‘bench to bedside’ research,” Dr. Fink says. READ MORE …
U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage Read More »